S. 3794
Senate Health, Education, Labor, and Pensions (HELP) Committee
Advanced by the Senate HELP Committee and awaiting further Senate action
What is the SAFE Drugs Act?
The SAFE Drugs Act is a proposed bill that would increase oversight and transparency for compounded drugs and the facilities that produce them. It is especially relevant to the growing use of compounded medications, including GLP-1 drugs.
What Would the Bill Do?
The bill would give the FDA more information about compounded drugs and increase oversight of certain compounding facilities. Key areas include:
01
Reporting serious adverse events
02
Reporting certain interstate drug distribution
03
Improving medication labeling
04
Increasing oversight of 503B outsourcing facilities
The bill would continue to allow legitimate compounding for patients who need customized medications.
Why Does It Matter?
Compounded medications can help patients who need a dosage or form of a medication that is not commercially available. However, they do not go through the same FDA approval process as commercially manufactured drugs.
The bill would give the FDA more information about compounded medications, including potential safety problems and how these drugs are distributed across state lines. It would also improve labeling so patients and healthcare providers can better distinguish compounded medications from FDA-approved products.
Current Status and Support
On July 22, 2026, the Senate HELP Committee approved the bill 17-5 and approved amendments. The bill has now moved beyond the introduction stage and could be considered by the full Senate.
The legislation has received support from organizations including the American Diabetes Association, National Association of Manufacturers, and Alliance for Safe Online Pharmacies.